Pharmicell Co., Ltd. (KRX:005690)
South Korea · Delayed Price · Currency is KRW 17,080
+730 (4.46%)
Last updated: Apr 9, 2026, 1:56 PM KST
Pharmicell Market Cap
Pharmicell has a market cap or net worth of 981.07 billion as of April 8, 2026. Its market cap has increased by 29.35% in one year.
Market Cap
981.07B
Enterprise Value
n/a
Revenue
23.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
17,080.00
Market Cap Chart
Since August 29, 1995, Pharmicell's market cap has increased from 40.96B to 981.07B, an increase of 2,295.18%. That is a compound annual growth rate of 10.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 981.07B | 12.53% |
| Dec 30, 2025 | 871.86B | 75.48% |
| Dec 30, 2024 | 496.83B | 36.41% |
| Dec 28, 2023 | 364.22B | -46.28% |
| Dec 29, 2022 | 678.05B | -13.33% |
| Dec 30, 2021 | 782.30B | -24.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 1.63T |
| Chabiotech | 1.58T |
| Onconic Therapeutics | 872.17B |
| GI Innovation | 847.90B |
| MEDIPOST | 766.47B |
| Proteina | 645.43B |
| Medy-Tox | 639.79B |
| Green Cross Holdings | 608.84B |